Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram

Reproductive BioMedicine Online

Volumn 17, Issue 5, 2008, Pages 632-641

  Freiesleben, Nina La Cour ^a   Lossl, K ^a   Bogstad, J ^b   Bredkjaer H E ^c   Toft, B ^d   Loft, A ^a   Bangsboll, S ^a   Pinborg, A ^a   Budtz Jorgensen E ^e   Andersen, A Nyboe ^a  

^a University of Copenhagen   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c HOLBÆK HOSPITAL   (Denmark)

^d HORSENS REGIONAL HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Intrauterine insemination; Nomogram; Ovarian stimulation; Predictive factors

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GANIRELIX; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CELL CYCLE; CLINICAL TRIAL; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRAUTERINE INSEMINATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MENSTRUAL CYCLE; NOMOGRAM; OVARY FOLLICLE; OVULATION INDUCTION; PREDICTION; SMOKING;

EID: 56749109928     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60310-0     Document Type: Article

References (33)

1. Allegra A, Marino A, Coffaro F et al. 2007 GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Human Reproduction 22, 101-108.
2. Balasch J 2004 Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility. Reproductive BioMedicine Online 9, 485-492.
3. Chang MY, Chiang CH, Chiu TH et al. 1998a The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program. Journal of Assisted Reproduction and Genetics 15, 12-17.
4. Chang MY, Chiang CH, Hsieh TT et al. 1998b Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertility and Sterility 69, 505-510.
5. Crosignani PG, Somigliana E 2007 Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Human Reproduction 22, 500-505.
6. Dickey RP, Taylor SN, Lu PY et al. 2002 Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertility and Sterility 78, 1088-1095.
7. Erdem M, Erdem A, Guler I et al. 2008 Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility. Fertility and Sterility 90, 360-366.
8. Goverde AJ, Lambalk CB, McDonnell J et al. 2005 Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates. Human Reproduction 20, 3141-3146.
9. Goverde AJ, McDonnell J, Vermeiden JPW et al. 2000 Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355, 13-18.
10. Guzick DS, Carson SA, Coutifaris C et al. for the National Cooperative Reproductive Medicine Network 1999 Efficacy of superovulation and intrauterine insemination in the treatment of infertility. New England Journal of Medicine 340, 177-183.
11. Hughes EG 1997 The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility. Human Reproduction 12, 1865-1872.
12. Iberico G, Vioque J, Ariza N et al. 2004 Analysis of factors influencing pregnancy rates in homologous intrauterine insemination. Fertility and Sterility 81, 1308-1313.
13. Lambalk CB, Leader A, Olivennes F et al. 2006 Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Human Reproduction 21, 632-639.
14. Magendzo A, Schwarze JE, de la Vega CD et al. 2006 Clomiphene citrate challenge test predicts outcome of intrauterine insemination in women aged under 37 years. Reproductive BioMedicine Online 12, 423-427.
15. Mannaerts BMJL, Rombout F, Out HJ et al. 1996 Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Human Reproduction Update 2, 153-161.
16. Matorras R, Ramon O, Exposito A et al. 2006 Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. Journal of Assisted Reproduction and Genetics 23, 51-54.
17. Ng EH, Yeung WS, Ho PC 2006 Patients with three or less dominant follicles may not be associated with reduced pregnancy rate of in vitro fertilization treatment. European Journal of Obstetrics, Gynecology and Reproductive Biology 129, 54-59.
18. Ng EH, Tang OS, Chan CC et al. 2005a Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment. Human Reproduction 20, 3147-3151.
19. Ng EH, Yeung WS, Ho PC 2005b The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination. Journal of Assisted Reproduction and Genetics 22, 323-328.
20. Ng EH, Tang OS, Ho PC 2000 The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Human Reproduction 15, 1937-1942.
21. Nuojua-Huttunen S, Tomas C, Bloigu R et al. 1999 Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Human Reproduction 14, 698-703.
22. Olufowobi O, Sharif K, Papaioannou S et al. 2005 Role of rescue IVF-ET treatment in the management of high response in stimulated IUI cycles. Journal of Obstetrics and Gynaecology 25, 166-168.
23. Park SJ, Alvarez JR, Weiss G et al. 2007 Ovulatory status and follicular response predict success of clomiphene citrate-intrauterine insemination. Fertility and Sterility 87, 1102-1107.
24. Popovic-Todorovic B, Loft A, Lindhard A et al. 2003a A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Human Reproduction 18, 781-787.
25. Popovic-Todorovic B, Loft A, Bredkjaeer HE et al. 2003b A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. Human Reproduction 18, 2275-2282.
26. Ragni G, Caliari I, Nicolosi AE et al. 2006 Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and Sterility 85, 619-624.
27. Sedbon E, Wainer R, Catherine P 2006 Quality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in France. Reproductive BioMedicine Online 12, 298-303.
28. Steinkampf MP, Hammond KR, Nichols JE et al. 2003 Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertility and Sterility 80, 99-102.
29. Steures P, van der Steeg JW, Mol BW et al. 2004 Prediction of an ongoing pregnancy after intrauterine insemination. Fertility and Sterility 82, 45-51.
30. Tinkanen H, Blauer M, Laippala P et al. 1999 Prognostic factors in controlled ovarian hyperstimulation. Fertility and Sterility 72, 932-936.
31. Tur R, Barri PN, Coroleu B et al. 2001 Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Human Reproduction 16, 2124-2129.
32. van Rumste MME, den Hartog JE, Dumoulin JCM et al. 2006 Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies? Human Reproduction 21, 701-704.
33. van Weert JM, van den Broek J, van der Steeg JW et al. 2007 Patients' preferences for intrauterine insemination or in-vitro fertilization. Reproductive BioMedicine Online 15, 422-427.